Pharmacopsychiatry

Article	Citations
Exposure to Psychotropic Drugs and Colorectal Cancer Risk in Patients with Affective Disorder: A Nested Case-Control Study	169
SARS-CoV-2-Infection in People Addicted to Illegal Drugs – Is There a Protective Effect of Opioid Maintenance Treatment?	65
	49
Twenty-Three Years of Declining Lithium Use: Analysis of a Pharmacoepidemiological Dataset from German-Speaking Countries	24
Neuronal Correlates of Delusional Symptomatology in Affective and Psychotic Disorders	23
2001–2021 Comparative Persistence of Oral Antipsychotics in Patients Initiating Treatment: Superiority of Clozapine in Time-to-Treatment Discontinuation	19
Challenges Related to the Implementation of Measurement-Based Care for the Treatment of Major Depressive Disorder: A Feasibility Study	19
Time-Dependent Effects of Metformin and Olanzapine on the Metabolic System	18
CircRNAs in Peripheral Blood: Potential Biomarkers for Alzheimer’s Disease?	17
The Role of Circadian Rhythmicity and CLOCK Genes in Psychiatry	17
The Mini-TRH Test	17
Predicting mental health symptoms with NBS-Predict	17
The Role of Mood Stabilizers in Children and Adolescents with Anorexia Nervosa: A 1-year Follow-Up, Propensity Score-Matched Study	15
Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports	15
	12
	12
GABAergic Effects of Etifoxine and Alprazolam Assessed by Double Pulse TMS	11
Recreational Cannabis Legalization: No Contribution to Rising Prescription Stimulants in the USA	11
Amphiphysin und GAD65 IgG Antikörper bei Zwangsstörungen	11
Epigenetics for Drug Discovery: Dissecting the Effect of High Antipsychotic Dosage and D2 Blockage on Peripheral DNA Methylation	11
News on the Role of Antidepressants in and for COVID-19 and Long COVID	9
Effects of Pharmacokinetic Gene Variation on Therapeutic Drug Levels and Antidepressant Treatment Response	8
Patient and Physician Exposure to Artificial Intelligence Hype	8
	8
Ausschreibung Peter Müller Preis für Forschung im Bereich Schizophrenie	7

Prevalence of COVID-19 and Psychotropic Drug Treatment in Psychiatric In-patients in Germany in 2020: Results from a Nationwide Pilot Survey	7
	7
Comparison of Sodium Lactate Infusion and Carbon Dioxide Inhalation Panic Provocation Tests: A Meta-analysis	6
Xanomeline-Trospium for Adults with Schizophrenia Experiencing Acute Psychosis: A Systematic Review and Meta-analysis of Safety and Tolerability Outcomes	6
Impaired nonverbal communication is associated with symptom severity in Depression	6
	6
	6
Longitudinal Multimodal Analysis of Structural Brain Changes and Psychopathology Using Data-Driven Fusion Approaches	5
Clinical Outcomes after Clozapine Discontinuation in Patients with Schizophrenia: A Systematic Review	5
Perceptions, Experiences, and Patterns of Cannabis Use in Individuals with Mood and Anxiety Disorders in the Context of Cannabis Legalization and Medical Cannab	5
Linkage of Young Mania Rating Scale to Clinical Global Impression Scale to Enhance Utility in Clinical Practice and Research Trials	5
Increased Odds of Cognitive Impairment in Adults with Depressive Symptoms and Antidepressant Use	5
Effects of Anesthesia Changes During Maintenance ECT: A Longitudinal Comparison of Seizure Quality Under Anesthesia Using Propofol/Esketamine Versus Methohexita	5
	5
Regulatory Alignment of Psilocybin Clinical Trials in Major Depressive Disorder on ClinicalTrials.gov: A Cross-Sectional Analysis	5
Monitoring Anesthetic Depth Using the Patient State Index in Electroconvulsive Therapy Improves Seizure Quality	4
Pharmacological Treatment of Early-Onset Schizophrenia: A Critical Review, Evidence-Based Clinical Guidance and Unmet Needs	4
The Relevance of Integrating CYP2C19 Phenoconversion Effects into Clinical Pharmacogenetics	4
Revisiting the World’s Strictest COVID-19 Lockdown: Formidable Mental Health Challenges	4
Cardiovascular Effects of Non-Selective Monoamine Oxidase Inhibitors and Intranasal Esketamine Combination in Depression – A Quasi-Experimental Design with Baye	4
Does Lidocaine Shorten Seizure Duration in Electroconvulsive Therapy?	4
Overview: Chronic Pain and Cannabis-Based Medicines	4
Das therapeutische Potential von niedrig dosiertem Δ9-Tetrahydrocannabinol bei der Modulation der Alzheimer-Pathologie im 5xFAD-Mausmodell	4
Predicting one-year postoperative cognitive dysfunction after cardiac surgery by combining markers of amyloid-β and tau pathology	3
In major depression early response to antidepressant treatment in week one is associated with FKBP5-gene variants rs1360780 and rs4713916	3
Reward System in Schizophrenia: Characterizing Clinical and Neurobiological Underpinnings with Regard to Sexuality	3
Brain Fog reconsidered. Objectifying subjective cognitive impairment following COVID-19 infection.	3
Impact of Antipsychotic Medications on Weight Gain and Eating Disorder-Related Psychopathology in Adult Inpatients with Anorexia Nervosa	3
Investigating the role of CCL11 in shaping microglial age-and long-COVID-related inflammatory activation	3
Metformin is Protective Against the Development of Mood Disorders	3
	3
	2
Digital Phenotyping and Mobile Sensing in Addiction Psychiatry	2
Development of a Genetic Test Indicating Increased AVP/V1b Signalling in Patients with Acute Depression	2
Medical Cannabis Legalization: No Contribution to Rising Stimulant Rates in the USA	2
Endocannabinoid Modulation Using Monoacylglycerol Lipase Inhibition in Tourette Syndrome: A Phase 1 Randomized, Placebo-Controlled Study	2
	2
Investigation of Stress-Induced Cortisol Effects on Decision Making After Pharmacological Mineralocorticoid or Glucocorticoid Receptor Blockade	2
Factors Associated with Antidepressant Effects of Ketamine: A Reanalysis of Double-Blind Randomized Placebo-Controlled Trial of Intravenous Ketamine for Treatme	2
Ausschreibung Peter Müller Preis für Forschung im Bereich Schizophrenie	2
Early Treatment-Resistance in First Episode Psychosis	1
Therapeutic Potential of the Novel GLP-1 Receptor Agonist Semaglutide in Alcohol Use Disorder	1
Systematic Review and Meta-Analysis of L-Methylfolate Augmentation in Depressive Disorders	1
Unraveling the Influence of Age, IQ, Education, and Negative Symptoms on Neurocognitive Performance in Schizophrenia: A Conditional Inference Tree Analysis	1
Einfluss einer traumafokussierten Psychotherapie auf Zwangs- und somatoformen Symptome: Design einer klinischen Längsschnittstudie	1
	1
Reward System in Schizophrenia: Characterizing Clinical and Neurobiological Underpinnings with Regard to Sexuality	1
Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine	1
Impact of Parkinson Medication on Neuropsychiatric and Neurocognitive Symptoms in Patients with Advanced Parkinson Disease Prior to Deep Brain Stimulation	1
Blood Cell Count Ratios at Baseline are Associated with Initial Clinical Response to Clozapine in Treatment-Resistant, Clozapine-Naïve, Schizophrenia-Spectrum D	1

CYP1A2 Genotyp-abhängige Auswirkung des Rauchens auf die Mirtazapin Serumkonzentration	1
Effectiveness of Medical Cannabis for the Treatment of Depression: A Naturalistic Outpatient Study	1
Early phase of a seronegative autoimmune psychosis with increased kappa free light chains	1
Serious Adverse Drug Reactions to Antipsychotics in Minors with Multiple Disabilities: Preventability and Potential Cost Savings by Therapeutic Drug Monitoring	1
Activation of Hippocampal Neuronal NADPH Oxidase NOX2 Promotes Depressive-Like Behaviour and Cognition Deficits in Chronic Restraint Stress Mouse Model	1
Human Derived Dermal Fibroblasts as in Vitro Research Tool to Study Circadian Rhythmicity in Psychiatric Disorders	1
Implications of Online Self-Diagnosis in Psychiatry	1
Cannabidiol and its Potential Evidence-Based Psychiatric Benefits – A Critical Review	0
Integrative Genetic Variation, DNA Methylation, and Gene Expression Analysis of Escitalopram and Aripiprazole Treatment Outcomes in Depression: A CAN-BIND-1 Stu	0
Citalopram als potenzielle Therapie und Prophylaxe für Alzheimer: Experimentelle Untersuchungen im 5xFAD-Mausmodell	0
	0
	0
Der Zusammenhang zwischen belastenden Lebensereignissen, DMN-Konnektivität und MDD- Remission: Eine fMRT-gestützte Analyse	0
Medicinal Use of Different Cannabis Strains: Results from a Large Prospective Survey in Germany	0
Dexmedetomidine in Psychiatry: Repurposing of its Fast-Acting Anxiolytic, Analgesic and Sleep Modulating Properties	0
Advancements in Non-Dopaminergic Treatments for Schizophrenia: A Systematic Review of Pipeline Developments	0
The Therapeutic Potential of Pimavanserin in the Treatment of Hallucinogen Induced Psychosis and Persistent Perceptual Symptoms	0
Therapeutic Reference Range for Clozapine Plasma Levels in Parkinson’s Disease or Dementia: A Systematic Review and Individual Participant Data Meta-analysis	0
„Peter Müller Preis für Forschung im Bereich Schizophrenie“ in Höhe von 5.000€	0
	0
COVID-19 Prognosis in Association with Antidepressant Use	0
	0
Medical Cannabis in Psychiatry	0
Ensemble Machine Learning Model for Real-Time Valproic Acid Prediction in Epilepsy Treatment	0
Differential impact of manic versus depressive episode recurrence on longitudinal gray matter volume changes in bipolar disorder	0
Association of Physical Activity and Bone Mineral Density in Adults with Depressive Symptoms	0
Correction: Electroconvulsive Therapy Versus Aripiprazole Addition to Clozapine in Patients with Clozapine-Resistant Symptoms (EMECLO): A Protocol of a Single-Blind, Multicenter, R	0
A Trajectory of Long-Term Antipsychotic Medication Dosage in Inpatients with Severe Behavioral and Psychological Symptoms of Dementia: A Retrospective Study	0
Interpersonal Needs, Mental Pain, and Hopelessness in Psychiatric Inpatients with Suicidal Ideation	0
Opportunities for Drug Repurposing of Serotonin Reuptake Inhibitors: Potential Uses in Inflammation, Infection, Cancer, Neuroprotection, and Alzheimer’s Disease	0
	0
Comparable Psychotropic Prescription Rates After Hospital Discharge Between Patients with COVID-19 and Those With Non-COVID-19-Related Respiratory Infection	0
Effects of Early Clozapine Treatment on Remission Rates in Acute Schizophrenia (The EARLY Trial): Protocol of a Randomized-Controlled Multicentric Trial	0
Association Study Between DRD2, DRD3 Genetic Polymorphisms and Adverse Reactions in Chinese Patients on Amisulpride Treatment	0
Rationale, Mission and Vision for a National Centre of Affective Disorders in Germany	0
The BIPCOVID Study: Investigating Shared Genetic Pathways Between COVID-19 Susceptibility and Psychiatric Symptoms in Bipolar Disorder	0
Entgiftung bei Alkoholabhängigen mit Clomethiazol oder Diazepam – Vergleich von Behandlungsvariablen	0
Predicting Future Cognitive Decline Using Novel fMRI-Based Biomarkers in Preclinical Alzheimer's Disease	0
Hirnvolumetrie bei Patienten mit Alkoholabhängigkeit	0
Challenges and Ethical Considerations to Successfully Implement Artificial Intelligence in Clinical Medicine and Neuroscience: a Narrative Review	0
Classic Psychedelic Drugs: Update on Biological Mechanisms	0
	0
How to Improve Methodological Issues in Clinical Trials to Confirm that Pentoxifylline is Useful as an Add-on Therapy for Major Depressive Disorder	0
	0
Factors Associated with Medication Adherence to Long-Acting Injectable Antipsychotics: Results from the STAR Network Depot Study	0
Cognitive Side Effects of Electroconvulsive Therapy: A Case-Control Comparison in Obsessive-Compulsive and Depressive Disorders	0
Pharmacological Treatment of Autism Spectrum Disorder: A Systematic Review of Treatment Guidelines	0
Effects of long-term thiethylperazine treatment on Alzheimer's pathology in Tg4-42 mice: Therapeutic Potential vs. Adverse Effects	0
Evaluation of E-Cigarette Use in Opioid-Dependent Patients in Maintenance Treatment	0
„AGNP-Preis für Forschung in der Psychopharmakologie“ in Höhe von 5.000 €	0
Instruments Assessing Medication Literacy in Psychiatric Patients and the Caregivers: A Systematic Review	0
Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry	0
Stratifizierung des Risikos für die Anwendung von Zwangsmaßnahmen mit Hilfe von künstlicher Intelligenz und elektronischen Gesundheitsdaten	0
Cannabinoids for Behavioral Symptoms in Dementia: An Overview	0
Diversion and Abuse of Prescribed Methylphenidate – A Survey of an Outpatient Clinic for Adult Persons with ADHD	0
Electroconvulsive Therapy Versus Aripiprazole Addition to Clozapine in Patients with Clozapine-Resistant Symptoms (EMECLO): A Protocol of a Single-Blind, Multic	0
	0
Candidate Psychotropics against SARS – CoV – 2: A Narrative Review	0
Expression Biomarkers of Pharmacological Treatment Outcomes in Women with Unipolar and Bipolar Depression	0
Was heißt hier Remission? Eine Sekundäranalyse der longitudinalen EMC-Studie	0
A Possible Type IV Hypersensitivity Reaction to Older Antiepileptic Drugs During and After Recovery from COVID-19 Infection	0
Neural links of paranoia in a transdiagnostic sample	0
Covid-19: Contributions from Psychopharmacology	0
Cariprazine Orodispersible Tablet: A New Formulation for Cariprazine	0
Lithium Therapy in Old Age: Recommendations from a Delphi Survey	0
Risk Phenotypes, Comorbidities, Pharmacotherapy, and Electroconvulsive Therapy (ECT) in a Cohort with Difficult-to-Treat Depression in Comparison to an Unmedica	0
Risperidone-Induced Leukoneutropenia: Evidence from a Positive Rechallenge and Review of the Literature	0
ABC Family Gene Polymorphisms and Cognitive Functions Interact to Influence Antidepressant Efficacy	0
A genome-wide association study of brain function across multiple cognitive domains	0
Augmentation of Electroconvulsive Therapy with Oral Caffeine: A Retrospective Analysis of 40 Patients with Major Depression	0
Discontinuation Rate of Lurasidone and Quetiapine Extended Release in Bipolar Depression	0
	0
Clozapine-Induced Stuttering: Case Report and Literature Review	0
Effect of Quetiapine, from Low to High Dose, on Weight and Metabolic Traits: Results from a Prospective Cohort Study	0
Selective Serotonin Reuptake Inhibitors may Influence COVID-19 Prognosis through Antioxidant and Cytoprotective Pathways Mediated by Sigma 1 Receptor Agonism	0
Impact of Psychiatric and Related Somatic Medications on the Duration and Severity of COVID-19: A Retrospective Explorative Multi-center Study from the German M	0
Geschlechter im Fokus: Welche Rolle spielt der 5-HT2C-Rezeptor in der lateralen Habenula in einem Mausmodell der schweren Depression?	0
Morphological Representation of C1q in the Aging Central Nervous System	0
Serious Adverse Drug Reactions in Children and Adolescents Treated On- and Off-Label with Antidepressants and Antipsychotics in Clinical Practice	0
Drug Combinations for Mood Disorders and Physical Comorbidities That Need Attention: A Cross-Sectional National Database Survey	0

COVID-19: Risks, Complications, and Monitoring in Patients on Clozapine	0
Identification of Endocannabinoid Predictors of Treatment Outcomes in Major Depressive Disorder: A Secondary Analysis of the First Canadian Biomarker Integratio	0
Longitudinal Digital Mood Charting in Bipolar Disorder: Experiences with ChronoRecord Over 20 Years	0
Arzneimittelsicherheit in der Psychiatrie Hautexanthem mit Eosinophilie unter Lithium	0
Anti-SARS-CoV-2 Action of Fluvoxamine may be Mediated by Endothelial Nitric Oxide Synthase	0
Effekte eines sechswöchigen hochfrequenten standardisierten Sportprogramms (SIWAS) auf die Herzfrequenzvariabilität bei Patient*innen mit psychiatrischen Erkrankungen	0
Association of Four Medication Classes and Non-suicidal Self-injury in Adolescents with Affective Disorders – A Retrospective Chart Review	0
Life-time Actionable Pharmacogenetic Drug Use: A Population-based Cohort Study in 86 040 Young People With and Without Mental Disorders in Denmark	0
Antipsychotic Monotherapy for Major Depressive Disorder: A Systematic Review and Meta-Analysis	0
Management of Refractory Functional Gastrointestinal Disorders: What Role Should Psychiatrists Have?	0
Strategies and Management for Psychiatric Drug Withdrawal: A Systematic Review of Case Reports and Series	0
Is Lumateperone Effective in Bipolar Depression? A Systematic Literature Review and Meta-Analysis on Placebo-Controlled Trials	0
Initial Evidence of CES1 Gene Variants Influencing the Pharmacokinetics and Clinical Effects of Methylphenidate	0
Rapid Antidepressant and Antisuicidal Effects of Low-Dose Ketamine Infusion in Patients With Treatment-Resistant Depression With or Without Low-Grade Inflammati	0
Valproic Acid Induced Thrombocytopenia in an Elderly Man with Schizoaffective Disorder: A Case Report	0
Low Escitalopram Concentrations in Patients with Depression predict Treatment Failure: A Naturalistic Retrospective Study	0
High Prescribing and State-Level Variation in Z-Drug Use Among Medicare Patients	0
Patient Perspectives on Pharmacotherapy of Alcohol Dependence	0
Establishing Core Symptoms of Acute Serotonin Reuptake Inhibitor Withdrawal: Results from an International Survey of Online Peer-Support Communities	0
DNA Methylation of POMC and NR3C1-1F and Its Implication in Major Depressive Disorder and Electroconvulsive Therapy	0
Neuroimaging-gestützte Charakterisierung von Schlafstörungen und Depressionen	0
An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels	0
Neuropsychiatric Drugs Against COVID-19: What is the Clinical Evidence?	0
Pentoxifylline as a Novel Add-on Therapy for Major Depressive Disorder in Adult Patients: A Randomized, Double-Blind, Placebo-Controlled Trial	0
Precision Psychiatry Approach to Treat Depression and Anxiety Targeting the Stress Hormone System – V1b-antagonists as a Case in Point	0
Transdiagnostic types of formal thought disorder and their association with gray matter brain structure: a model-based cluster analytic approach	0
	0
	0
Untersuchung des Sozialverhaltens in einem Rattenmodell der bipolaren Störung	0
Influence of NOS1AP Risk Variants on the Corrected QT (QTc) Interval in the Pharmacotherapy of Schizophrenia	0
Correction: Lithium Therapy in Old Age: Recommendations from a Delphi Survey	0
	0
Therapeutic Drug Monitoring of Cariprazine – Updated Values for a Dose-Related Reference Range	0
Influence of Glutamate Neurotransmission Genes on the Outcomes of Antipsychotic Treatments	0
Cannabinoids in the Treatment of Selected Mental Illnesses: Practical Approach and Overview of the Literature	0
Aripiprazole Once-Monthly Versus Oral Aripiprazole for Schizophrenia in the Maintenance Phase: A Systematic Review and Network Meta-Analysis	0
Baseline Working Memory Predicted Response to Low-Dose Ketamine Infusion in Patients with Treatment-Resistant Depression	0
The Effect of Electroconvulsive Therapy on Specific Catatonia Symptoms and Predictors of Late Response	0